Jetbest Corporation AI Stock Analysis
Jetbest Corporation (4741) AI Stock Analysis
Jetbest Corporation
(TPEx:4741)
The overall score of 47 reflects a high-risk profile. The primary drag is the company's very weak financial performance, marked by collapsing profitability and cash flow, which is compounded by an extremely expensive valuation (P/E of 51.8). The only positive driver is moderately bullish technical momentum, suggesting the market may be pricing in a future recovery not yet evident in the fundamentals. The strong balance sheet provides some downside protection but is not enough to offset the severe operational deterioration.
Jetbest Corporation (4741) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.04B
- Dividend Yield
- 0.50%
- Average Volume (3M)
- 578.22K
- Price to Earnings (P/E)
- 42.9
- Beta (1Y)
- 0.60
- Revenue Growth
- 5.77%
- EPS Growth
- 157.11%
- Country
- TW
- Employees
- 98
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Jetbest Corporation Business Overview & Revenue Model
Company Description
Jetbest Corporation is a global enterprise focused on the research, development, manufacturing, and distribution of inkjet printing products, serving markets in Taiwan and worldwide. Their extensive product line encompasses a diverse array of inks, i...
Jetbest Corporation Financial Statement Overview
Summary
Financial performance is severely strained. The income statement (score 28) shows persistent revenue decline and collapsing margins, while cash flow (score 18) has nearly evaporated, signaling high liquidity risk. The strong balance sheet (score 72) provides a buffer, but the dominant trend is a sharp deterioration in earnings and cash generation.
Income Statement
28NegativeBalance Sheet
72PositiveCash Flow
18Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 525.23M | 484.90M | 590.08M | 648.57M | 724.51M | 630.20M |
| Gross Profit | 172.41M | 131.25M | 202.78M | 200.86M | 178.10M | 159.10M |
| EBITDA | 78.77M | 51.94M | 125.60M | 116.48M | 104.14M | 76.89M |
| Net Income | 42.04M | 10.11M | 65.26M | 66.20M | 55.13M | 29.67M |
Balance Sheet | ||||||
| Total Assets | 1.15B | 1.12B | 1.14B | 1.17B | 1.17B | 1.17B |
| Cash, Cash Equivalents and Short-Term Investments | 364.67M | 359.75M | 375.86M | 382.89M | 278.91M | 230.28M |
| Total Debt | 98.33M | 97.45M | 83.88M | 95.59M | 92.63M | 121.10M |
| Total Liabilities | 219.38M | 197.70M | 189.80M | 223.71M | 235.16M | 260.23M |
| Stockholders Equity | 928.48M | 910.55M | 939.97M | 933.96M | 913.61M | 885.31M |
Cash Flow | ||||||
| Free Cash Flow | 20.02M | 9.23M | 72.10M | 145.02M | 100.42M | -38.15M |
| Operating Cash Flow | 38.39M | 36.66M | 110.01M | 156.67M | 103.46M | 57.13M |
| Investing Cash Flow | -114.22M | -123.56M | -40.86M | -9.36M | -2.83M | -91.86M |
| Financing Cash Flow | -33.11M | -25.65M | -76.15M | -41.52M | -53.38M | 4.92M |
Jetbest Corporation Peers Comparison
Overall Rating
TW:652773Outperform
TW:413868Neutral
TW:411662Neutral
TW:417560Neutral
TW:474753Neutral- TW:474147Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:6527 | 73Outperform | TWD 1.86B | 12.15 | ― | 3.98% | -1.23% | 10.20% |
| TW:4138 | 68Neutral | TWD 2.15B | 15.66 | ― | 7.75% | -1.10% | -16.90% |
| TW:4116 | 62Neutral | TWD 1.82B | 2.38 | ― | 4.91% | 3.85% | 786.65% |
| TW:4175 | 60Neutral | TWD 2.09B | 13.16 | ― | 6.00% | 2.49% | 5.18% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:4747 | 53Neutral | TWD 1.60B | -23.25 | ― | 3.32% | 4.56% | -172.55% |
| TW:4741 | 47Neutral | TWD 2.09B | 42.95 | ― | 0.50% | 5.77% | 157.11% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4741 | Jetbest Corporation | 57.80 | 36.25 | 168.23% | |
| TW:4116 | BenQ Medical Technology Corp. | 40.80 | -2.53 | -5.83% | |
| TW:4138 | Dynamic Medical Technologies Inc. | 54.20 | -5.23 | -8.80% | |
| TW:4175 | MedFirst Healthcare Services, Inc. (TW) | 49.80 | -4.10 | -7.60% | |
| TW:4747 | Johnson Chemical Pharmaceutical Works Co., Ltd. | 14.35 | -16.88 | -54.05% | |
| TW:6527 | Crystalvue Medical Co Ltd | 72.80 | -5.63 | -7.18% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026